WNT5A and neoplasm: With WNT5A being one of only seven genes significantly upregulated in SIX1/2-Q177R tumors compared to other blastemal tumors in both expression datasets (Fig. 1A), it is a strong candidate for promoting tumor progression and the chemotherapeutic resistance associated with SIX1/2-Q177R.